Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Number of holders
-
239
-
Total 13F shares, excl. options
-
4,955,742
-
Shares change
-
-287,534
-
Total reported value, excl. options
-
$802,113,791
-
Value change
-
-$46,741,875
-
Put/Call ratio
-
115%
-
Number of buys
-
73
-
Number of sells
-
-108
-
Price
-
$161.96
Significant Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q4 2021
270 filings reported holding FBT - FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH as of Q4 2021.
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) has 239 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,955,742 shares
.
Largest 10 shareholders include MORGAN STANLEY (817,318 shares), WELLS FARGO & COMPANY/MN (524,452 shares), BANK OF AMERICA CORP /DE/ (452,342 shares), UBS Group AG (327,120 shares), LPL Financial LLC (265,458 shares), Raymond James Financial Services Advisors, Inc. (234,873 shares), ROYAL BANK OF CANADA (205,735 shares), RAYMOND JAMES & ASSOCIATES (133,973 shares), Berger Financial Group, Inc (125,010 shares), and ADVISOR GROUP HOLDINGS, INC. (124,324 shares).
This table shows the top 239 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.